Shukra Pharmaceuticals Ltd
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹856.71Cr
PE Ratio
59.29
Shukra Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Shukra Pharmaceuticals Ltd Fundamentals
Shukra Pharmaceuticals Ltd Delivery and Volume
About Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the busi
| Name | Designation |
|---|---|
| Dakshesh Shah | Chairman & Managing Director |
| Payal Mehta | Executive Director |
| Bhoomiben Patel | Independent Director |
| Sarjeevan Singh | Independent Director |
| Sonal Deepalbhai Gandhi | Independent Director |
| Sanskruti Patel | Whole Time Director |
| Dhruvin Shah | Whole Time Director |
| Pinki Nirmal Sagar | Independent Director |
| Anar Jayesh Patel | Whole Time Director |
| Jitendra shah | Independent Director |
| Arpita Kabraa | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Shukra Pharmaceuticals Ltd FAQs
How do I Buy Shukra Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Shukra Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Shukra Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Shukra Pharmaceuticals Ltd's share price is ₹195.65 as of 2025-01-15.
What is the PE ratio of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd's P/E ratio is 59.29 times as of 2025-01-15.
What is the PB ratio of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 15.78, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Shukra Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Shukra Pharmaceuticals Ltd's market capitalization is ₹856.71 Cr as on 2025-01-15.
What is the ROE of Shukra Pharmaceuticals Ltd?
The current financial records of Shukra Pharmaceuticals Ltd show a 44.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Shukra Pharmaceuticals Ltd?
According to Shukra Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹56.23, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Shukra Pharmaceuticals Ltd?
The 52-week high/low price of a Shukra Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Shukra Pharmaceuticals Ltd's 52-week high and low as of 2025-01-15 are ₹195.65 and ₹195.65, respectively.
